Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

CLDN6 CAR-T cell therapy (BioNTech)

Generic Name: CLDN6 CAR-T cell therapy (BioNTech)

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm

Phase 2

Not yet recruiting

Posted: 2025/04/23

Sponsor:BioNTech SE

ID:NCT06940804

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

Novel CLDN6-Targeted Therapies Show Promise in Advanced Solid Tumors

4 months ago

Recent clinical trials demonstrate encouraging efficacy of CLDN6-directed antibody-drug conjugates DS-9606 and TORL-1-23 in treating various solid tumors, with response rates up to 50% in CLDN6-positive platinum-resistant ovarian cancer.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy